The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

APH ALLIANCE PHARMA PLC ORD 1P



Income Statement  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
Revenue  49.88 45.96 44.90 45.28 43.54
Operating Profit/(Loss)  16.97 12.34 12.32 13.31 11.17
Net Interest  2.20 1.57 1.52 1.26 0.99
Profit Before Tax  12.87 10.71 10.81 12.01 10.16
Profit After Tax  8.95 8.64 8.69 9.58 8.39
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  8.95 8.64 8.69 9.58 8.39
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  8.95 8.64 8.69 9.58 8.39
 
Continuing EPS
Earnings per Share - Basic  3.96p 3.62p 3.61p 3.82p 3.17p
Earnings per Share - Diluted  3.64p 3.39p 3.40p 3.68p 3.16p
Earnings per Share - Adjusted  5.07p 3.62p 3.61p 3.82p 3.36p
Continuing and Discontinued EPS
Earnings per Share - Basic  3.96p 3.62p 3.61p 3.82p 3.17p
Earnings per Share - Diluted  3.64p 3.39p 3.40p 3.68p 3.16p
Earnings per Share - Adjusted  5.07p 3.62p 3.61p 3.82p 3.36p
 
Dividend per Share  0.30p 0.57p 0.75p 0.83p 0.91p

Balance Sheet  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Assets
Non-Current Assets
Property, Plant & Equipment  0.89 0.77 0.49 0.59 0.40
Intangible Assets  60.29 66.13 79.89 87.11 88.88
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.53 1.27
Other Financial Assets  0.00 0.00 0.00 0.44 0.00
Other Non-Current Assets  0.00 0.00 0.08 1.46 1.66
  61.18 66.90 80.45 90.14 92.20
Current Assets
Inventories  4.54 5.65 5.39 5.47 5.91
Trade & Other Receivables  9.69 8.66 10.15 10.64 8.32
Cash at Bank & in Hand  1.99 1.08 4.63 0.69 1.43
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  16.22 15.39 20.17 16.80 15.67
 
Total Assets  77.40 82.29 100.63 106.94 107.87
 
Liabilities
Current Liabilities
Borrowings  -4.00 -4.25 -10.44 -5.02 -3.31
Other Current Liabilities  -12.98 -9.61 -11.61 -9.88 -8.11
  -16.98 -13.86 -22.05 -14.90 -11.42
 
Net Current Assets  -0.76 1.53 -1.87 1.90 4.26
 
Non-Current Liabilities
Borrowings  -19.82 -19.69 -20.23 -20.88 -19.24
Provisions  -4.44 -4.57 -6.49 -6.49 -6.31
Other Non-Current Liabilities  -0.07 -0.04 -0.02 0.00 -0.13
  -24.34 -24.30 -26.73 -27.37 -25.67
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -41.32 -38.16 -48.78 -42.27 -37.09
 
Net Assets  36.08 44.13 51.85 64.67 70.78
 
Capital & Reserves
Share Capital  2.36 2.40 2.43 2.64 2.64
Share Premium Account  24.33 24.87 25.30 29.38 29.39
Other Reserves  -0.11 0.09 0.46 1.45 1.56
Retained Earnings  9.49 16.77 23.66 31.20 37.19
Shareholders Funds  36.08 44.13 51.85 64.67 70.78
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  36.08 44.13 51.85 64.67 70.78

Ratios - based on IFRS 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
PE Ratio - Adjusted  6.11 8.53 8.80 10.60 10.86
PEG - Adjusted  0.14 -0.30 -31.43 1.82 -0.90
Earnings per Share Growth - Adjusted  42.82% -28.60% -0.28% 5.82% -12.04%
Dividend Cover  16.90 6.35 4.81 4.63 3.70
Revenue Per Share  22.06p 19.26p 18.64p 18.05p 16.48p
Pre-Tax Profit per Share  5.69p 4.49p 4.49p 4.79p 3.85p
Operating Margin  30.21% 26.72% 27.45% 29.30% 24.75%
Return on Capital Employed  371.21% 188.74% 135.28% 133.33% 103.58%
 
Continuing & Discontinued Operations
Dividend Yield  0.97% 1.85% 2.36% 2.04% 2.49%
Dividend per Share Growth  n/a 90.00% 31.58% 10.00% 10.06%
Net Asset Value per Share (exc. Intangibles)  -10.25p -9.19p -11.54p -8.50p -6.85p
Net Gearing  60.51% 51.79% 50.20% 38.99% 29.82%

Data is provided by Morningstar

Market

Company Information
Updated Monthly
Company address Avonbridge House, 2 Bath Road, Chippenham, SN15 2BB, United Kingdom
Company website http://www.alliancephar...
Market cap(in millions)* £ 147.88
Listing/Admission to trading 23 Dec 2003
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
02-Sep-15
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIM
MiFID Status MTF
Exchange market size 7,500
SEDOL 3103081
ISIN number GB0031030819



ALLIANCE PHARMA share - fundamentals